A novel predicitve model of urinary tract recurrence in urothelial cancer by comprehensive analyses of urine immunocomplex
A novel predicitve model of urinary tract recurrence in urothelial cancer by comprehensive analyses of urine immunocomplex
批准号:
16K15690
负责人:
MIYATA Yasuyoshi
金额:
$2.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2016
资助国家:
日本
项目状态:
已结题
起止时间:
2016-04-01 至 2019-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.
人类抗原 R 作为晚期顺铂耐药尿路上皮癌对吉西他滨化疗反应的预测标记。
DOI:
10.3892/ol.2016.5484
发表时间:
2017
期刊:
Oncology Letters
影响因子:
2.9
作者:
[Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.]
通讯作者:
Sakai H.
Green Tea Polyphenol Induces Changes in Cancer-Related Factors in an Animal Model of Bladder Cancer.
DOI:
10.1371/journal.pone.0171091
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Matsuo T, Miyata Y, Asai A, Sagara Y, Furusato B, Fukuoka J, Sakai H]
通讯作者:
Sakai H
Investigation on clinicopathological signficance and tumor suppressive effects of 4N1K-peptide in bladder cancer
-
批准号:25462487
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:MIYATA Yasuyoshi
-
依托单位:
海外基金